Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
January 10, 2020
Akouos Announces Senior Leadership Team Appointments
January 10, 2020
Crossroads Treatment Centers Teams with Pear Therapeutics to Bring the First Ever Digital Therapy to an Opioid Addiction Treatment Program
January 10, 2020
Impel NeuroPharma Announces Appointment of Adrian Adams as Chairman of the Board of Directors
January 8, 2020
Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
January 8, 2020
Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People
January 7, 2020
Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer
January 7, 2020
Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutics and Digital Biomarker Technologies
December 19, 2019
RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing
December 19, 2019
IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors
December 18, 2019
Pear Therapeutics Announces First Patient Dosed in Part II of Pear-006 Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
« Previous Page
1
…
58
59
60
61
62
…
118
Next Page »